SCHEMBL6746497

SCHEMBL6746497

COC[C@]12CC[C@H]3[C@@H](CC=C4CCCC[C@@]43C)[C@@H]1CCC2=O

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 13/20 0.72
CYP1B1 Q16678 1/20 0.56
LMNA P02545 2/20 0.50
CYP3A4 P08684 2/20 0.50
PMP22 Q01453 2/20 0.50
TSHR P16473 2/20 0.50
MEN1 O00255 1/20 0.50
SHBG P04278 1/20 0.50
SERPINA6 P08185 1/20 0.50
GUSB P08236 1/20 0.50
G6PD P11413 1/20 0.50
KMT2A Q03164 1/20 0.50
GPBAR1 Q8TDU6 1/20 0.50
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
BLM P54132 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8466445 0.88 CYP19A1 (0.67) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL1560756 0.87 CYP19A1 (0.77) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL1428474 0.87 CYP19A1 (0.66) CYP19A1CYP1B1CYP3A4CYP2C9CYP2C19
SCHEMBL29763604 0.87 CYP19A1 (0.62) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL6745364 0.86 CYP19A1 (0.65) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL29882586 0.86 CYP19A1 (0.65) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL8532535 0.86 CYP19A1 (0.75) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL4448095 0.86 CYP19A1 (0.79) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL4243919 0.86 CYP19A1 (0.75) CYP19A1CYP1B1LMNACYP3A4PMP22
SCHEMBL8639067 0.86 CYP19A1 (0.75) CYP19A1CYP1B1LMNACYP3A4PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1372664-A1 USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES Hollis-Eden Pharmaceuticals Inc. (US) 2004-01-02 EP disclosed
WO-2002069977-A1 USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES HOLLIS-EDEN PHARMACEUTICALS, INC. (US) 2002-09-12 WO disclosed